{"componentChunkName":"component---src-templates-lie-template-tsx","path":"/lie/8287/","result":{"pageContext":{"id":"8287","location":"Remarks","claim":"“We will be saving — I don't even want to say thousands, because I think it’s going to be much more, thousands and thousands, hundreds of thousands. We're going to be saving tremendous numbers of lives.”","analysis":"Trump signed the \"Right to Try\" law, which allows patients and doctors to ask drug companies directly for access to the experimental drugs, rather than wait for approval by the Food and Drug Administration. But the effect of similar state laws has been muted because obtaining the medicines from manufacturers can be more cumbersome than going through an existing FDA program, according to <a target=\"_blank\" href=\"https://www.bakerinstitute.org/media/files/files/8c781c33/CHB-pub-PolicyReport66.pdf\">a 2016 Rice University study</a>. A <a target=\"_blank\" href=\"https://med.nyu.edu/pophealth/sites/default/files/pophealth/Kearns%20BatemanHouse%20RTT%20variations%20in%20TIRS.pdf\">2017 New York University report</a> looked at the impact of a Colorado law and found no documented case of anyone receiving access, because of a right-to-try law, to an experimental product that would not have been available through the existing FDA program. Thus experts said that Trump's prediction of \"hundreds of thousands\" of lives being saved was highly unrealistic.","pinocchios":"","category":"Health care","repeated_ids":"","repeated_count":"0","date":"05/30/2018","portfolio":"lie"}},"staticQueryHashes":["3649515864"]}